OTCMKTS:SVNTQ - Savient Pharmaceuticals Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$0.0019 0.00 (0.00 %)
(As of 07/16/2018 12:28 PM ET)
Previous Close$0.0019
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average Volume340,036 shs
Market Capitalization$139,409.00
P/E RatioN/A
Dividend YieldN/A
Beta1.8
Savient Pharmaceuticals logoSavient Pharmaceuticals, Inc. (Savient), incorporated in 1980, is a specialty biopharmaceutical company focused on commercializing KRYSTEXXA (pegloticase) in the United States and completing the development and seeking regulatory approval outside of the United States for KRYSTEXXA, particularly in the European Union. The Company also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. In October 2013, the Company announced that it has elected to file voluntary petitions under Chapter 11 of the Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware (the Court). Effective January 10, 2014, Crealta Pharmaceuticals LLC, a majority owned unit of GTCR LLC acquired Savient Pharmaceuticals Inc.

Receive SVNTQ News and Ratings via Email

Sign-up to receive the latest news and ratings for SVNTQ and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolOTCMKTS:SVNTQ
CUSIPN/A
Phone+1-732-4189300

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares73,370,000
Market Cap$0.14

The Truth About Cryptocurrencies

Savient Pharmaceuticals (OTCMKTS:SVNTQ) Frequently Asked Questions

What is Savient Pharmaceuticals' stock symbol?

Savient Pharmaceuticals trades on the OTCMKTS under the ticker symbol "SVNTQ."

What is the consensus analysts' recommendation for Savient Pharmaceuticals?

0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Savient Pharmaceuticals in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."

Has Savient Pharmaceuticals been receiving favorable news coverage?

News articles about SVNTQ stock have trended somewhat negative recently, according to Accern. Accern scores the sentiment of press coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Savient Pharmaceuticals earned a coverage optimism score of -0.05 on Accern's scale. They also assigned media coverage about the biopharmaceutical company an impact score of 46.74 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the near future.

How do I buy shares of Savient Pharmaceuticals?

Shares of SVNTQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Savient Pharmaceuticals' stock price today?

One share of SVNTQ stock can currently be purchased for approximately $0.0019.

How big of a company is Savient Pharmaceuticals?

Savient Pharmaceuticals has a market capitalization of $139,409.00.

How can I contact Savient Pharmaceuticals?

Savient Pharmaceuticals' mailing address is 1 Tower Center Blvd, EAST BRUNSWICK, NJ 08816-1145, United States. The biopharmaceutical company can be reached via phone at +1-732-4189300.


MarketBeat Community Rating for Savient Pharmaceuticals (OTCMKTS SVNTQ)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  63 (Vote Outperform)
Underperform Votes:  92 (Vote Underperform)
Total Votes:  155
MarketBeat's community ratings are surveys of what our community members think about Savient Pharmaceuticals and other stocks. Vote "Outperform" if you believe SVNTQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SVNTQ will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/16/2018 by MarketBeat.com Staff

Featured Article: Analyst Ratings

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.